|
|
Article: Gene Logic Identifies Gene Expression Patterns Associated with Multiple Sclerosis in Blood Cells.
- Article from:
- Business Wire
- Article date:
- October 25, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company Is Collaborating with Accelerated Cure Project for Follow-On Studies Using Blood Samples
GAITHERSBURG, Md. -- Gene Logic Inc. (NASDAQ:GLGC) announced today that it has identified gene expression patterns in white blood cells (WBC) that are statistically associated with multiple sclerosis (MS), a disease of the central nervous system (CNS). The company's genomic analysis also identified gene patterns associated with two recently approved therapies for MS. To validate and extend its initial positive findings, Gene Logic is performing additional studies using blood samples from the repository of the Accelerated Cure Project for Multiple Sclerosis (ACP), a ...
Related newspaper, magazine, and journal articles:
|
|
Article: Gene Logic Agrees to Sell Genomics Assets.
Business Wire;
October 15, 2007 ;
700+ words
... ... Development Business GAITHERSBURG, Md. -- Gene Logic Inc. (NASDAQ: GLGC) announced today ... enabling company. Under the agreement, Gene Logic will exchange its genomics assets to ... conditions, including the approval of the Gene Logic shareholders who will be asked to authorize ...
|
|